Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 30, Pages 12426-12431
Publisher
Proceedings of the National Academy of Sciences
Online
2013-07-09
DOI
10.1073/pnas.1305207110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ERK-Mediated Phosphorylation of Fibroblast Growth Factor Receptor 1 on Ser777 Inhibits Signaling
- (2013) M. Zakrzewska et al. Science Signaling
- Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells
- (2012) Zu-Yau Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer-Associated Loss-of-Function Mutations Implicate DAPK3 as a Tumor-Suppressing Kinase
- (2011) J. Brognard et al. CANCER RESEARCH
- TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway
- (2011) S. Kant et al. GENES & DEVELOPMENT
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing
- (2011) Mitchell S Stark et al. NATURE GENETICS
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- (2011) Peter S. Hammerman et al. Cancer Discovery
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy
- (2010) Adi F. Gazdar CANCER AND METASTASIS REVIEWS
- ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
- (2010) David E. Gerber et al. CANCER CELL
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- Somatic EGFR Mutation and Gene Copy Gain as Predictive Biomarkers for Response to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
- (2009) I. J. Dahabreh et al. CLINICAL CANCER RESEARCH
- Statistical methods for analysis of high-throughput RNA interference screens
- (2009) Amanda Birmingham et al. NATURE METHODS
- p21 activated kinase 5 activates Raf-1 and targets it to mitochondria
- (2008) Xiaochong Wu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MIXED LINEAGE KINASE INHIBITOR CEP- 1347 FAILS TO DELAY DISABILITY IN EARLY PARKINSON DISEASE
- (2008) L. H. Wang et al. NEUROLOGY
- Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia
- (2008) S.-J. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- UnPAKing the class differences among p21-activated kinases
- (2008) Jeyanthy Eswaran et al. TRENDS IN BIOCHEMICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now